Merck Stock: The Battle Among Weight-Loss Drugs Has A New Contender
Merck stock wavered Tuesday after unveiling new data for a potential competitor to weight-loss drugs from Novo Nordisk and Eli Lilly.
Source: investors.com
📰 Evercore Raffat News
Evercore Raffat News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evercore Raffat. Real-time updates on events, politics, business and more.